World's top intensive care body advises against remdesivir for sickest COVID patients ...Middle East

Yahoo - News
Worlds top intensive care body advises against remdesivir for sickest COVID patients
Antiviral remdesivir should not be used as a routine treatment for COVID-19 patients in critical care wards, the head of one of the world's top bodies representing intensive care doctors said, in a blow to the drug developed by U.S. firm Gilead . Remdesivir, also known as Veklury, and steroid dexamethasone are the only drugs authorised to treat COVID-19 patients across the world. In light of the new interim data from the WHO's Solidarity trial "remdesivir is now classified as a drug you should not use routinely in COVID-19 patients," the President of the European Society of Intensive Care Medicine (ESICM), Jozef Kesecioglu, said in an interview with Reuters.

Hence then, the article about world 39 s top intensive care body advises against remdesivir for sickest covid patients was published today ( ) and is available on Yahoo ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( World's top intensive care body advises against remdesivir for sickest COVID patients )

Apple Storegoogle play

Last updated :

Also on site :